Larry Zeitlin received a B.A. in Biophysics and his doctorate in Reproductive Biology from The Johns Hopkins University.
After serving as a Research Scientist at ReProtect, LLC (Baltimore, MD), and a Senior Scientist at Epicyte Pharmaceutical (San Diego, CA), together with Dr. Kevin Whaley, he co-founded Mapp Biopharmaceutical and LeafBio, Inc. (San Diego, CA).
He has been an adjunct faculty member of the Biodesign Institute at Arizona State University since 2004.
Larry's career focus has been on the development of monoclonal antibody based products to address unmet public health needs in infectious disease.